The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Shareholder engagement update on 2020 AGM vote

19 Nov 2020 07:00

RNS Number : 7960F
Allied Minds PLC
19 November 2020
 

19 November 2020

 

Allied Minds plc

 

Shareholder engagement update on 2020 Annual General Meeting vote

 

Allied Minds plc (LSE: ALM), the IP commercialisation company focused on early stage technology businesses, reports that in accordance with the UK Corporate Governance Code and the commitment it made after its 2020 Annual General Meeting, it has consulted with and received feedback from its major shareholders regarding the company's remuneration report for the year ended 31 December 2019. Although the resolution to approve the remuneration report was successfully passed with the requisite majority at the 2020 Annual General Meeting, it received more than 20% of votes against the resolution. After extensive engagement with its major shareholders, the Board notes that shareholder concerns were focused on remuneration schemes in place for 2019 and prior that have since been addressed. Accordingly, the Board believes that the substantial amendments the company made to its remuneration programme for 2020 and onwards, as detailed in its 2019 Annual Report and Accounts, have and continue to appropriately address shareholder concerns and no further modifications are necessary at this time.

 

Enquiries

 

Allied Minds

c/o Instinctif Partners

Joseph Pignato

 

 

Instinctif Partners

 

Adrian Duffield, Kay Larsen, Chantal Woolcock

AlliedMinds@instinctif.com

 

About Allied Minds

 

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now manages and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services.

 

For more information, please visit www.alliedminds.com.

 

Allied Minds Forward‐Looking Statement

 

This press release contains statements that are or may be forward‐looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward‐looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward‐looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward‐looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward‐looking statements, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPGWPGUPUGRR
Date   Source Headline
9th Oct 20147:00 amRNSSubsidiary Spin Transfer Technologies Raises $70 M
7th Oct 20147:00 amRNSAllied Minds Launches Novare Pharmaceuticals
3rd Oct 20147:00 amRNSABLS Appoints Satish Jindal
2nd Sep 20145:12 pmRNSHolding(s) in Company
28th Aug 20147:00 amRNSAllied Minds Announces Half-Yearly Results
28th Aug 20147:00 amRNSHalf Yearly Report
27th Aug 20147:00 amRNSFormation of Whitewood Encryption Systems, Inc.
4th Aug 20147:00 amRNSAllied Minds and BMS Form New Enterprise
24th Jul 20143:18 pmRNSDirector/PDMR Shareholding
21st Jul 20147:00 amRNSPartial Exercise of Over-allotment Option
21st Jul 20147:00 amRNSEnd of Stabilisation Notice
25th Jun 20148:04 amRNSAdmission to Trading on the London Stock Exchange
20th Jun 20144:59 pmRNSPublication of Prospectus
20th Jun 20147:01 amRNSStabilisation Notice
20th Jun 20147:00 amRNSInitial Public Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.